Global Strategic

 
Fund Quotes for Global Strategic top ^
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for osicx investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for sdsix investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 4 Stars
Sign-up for sdsyx investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 2 Stars
Sign-up for opsgx investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 2 Stars
Sign-up for opsix investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for sdsax investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for sldsx investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for osiyx investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for osinx investment picks
  • Holdings: US Treasury Bond 8.875% , United Kingdom (Government Of) 8.75% , US Treasury Note 1.375% , US Treasury Note 3.125% , Canada Govt 4% ,
  • Category: World Allocation
Sign-up for mgryx investment picks
  • Holdings: US Treasury Bond 8.875% , United Kingdom (Government Of) 8.75% , US Treasury Note 1.375% , US Treasury Note 3.125% , Canada Govt 4% ,
  • Category: World Allocation
Sign-up for mgrnx investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for osiix investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for opsix investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 4 Stars
Sign-up for sdsax investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for lwsix investment picks
  • Category: Multisector Bond
  • Morningstar Rating: 3 Stars
Sign-up for LWSIX investment picks

 
News Articles for Global Strategic top ^
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - - Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. - - Infinity to Host Conference Call Today at 8:30 A.M. ET/7:30 A.M. CT - CAMBRIDGE, Mass.
Sign-up for Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.
Sign-up for Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology investment picks
Consulting expertise and automated tools provide real-time visibility into IT costs to enhance Technology Business Management capabilities STAMFORD, Conn.
Sign-up for ISG and Apptio Announce Global Strategic Partnership to Help CIOs Gain Transparency into IT Spend investment picks
Abcam plc, a global leader in the manufacture and supply of innovative protein research tools and services, and Cell Marque Corporation, a provider of antibodies and reagents for diagnostic immunohistochemistry, announced today they have signed a global 10-year strategic marketing agreement for Abcam’s in vitro diagnostic (IVD) immunohistochemistry (IHC) RabMAb ® primary antibody portfolio.
Sign-up for Abcam and Cell Marque Sign Global Strategic Marketing Agreement For IVD IHC RabMAb Antibodies investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Global Strategic
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Global Stock Funds  |  Next: Global Strategies